Displaying items by tag: Perrigo Co plc
Perrigo CEO sees Grand Rapids Medical Mile as potential ‘Silicon Valley of self-care’
GRAND RAPIDS — Executives at Perrigo Co. plc believe the company’s new North American headquarters will fit in neatly with the city of Grand Rapids’ burgeoning health care sector along Medical Mile.
Perrigo to relocate North American HQ to downtown Grand Rapids
GRAND RAPIDS — Perrigo Co. plc is relocating its North American corporate headquarters to downtown Grand Rapids, MiBiz has learned.
MiBiz Growth Report: August 16, 2020
MiBiz growth report for August 16, 2020.
Perrigo inks deal to buy 3 brands from Sanofi
ALLEGAN — Perrigo Co. plc intends to buy three skin care and hair loss brands from French pharmaceutical company Sanofi.
Perrigo reports boost in Q2 sales
Perrigo Co. plc grew sales more than 6 percent in the second quarter as earlier high demand eased for some medications during the COVID-19 pandemic.
MiBiz Growth Report: June 21, 2020
Here is the MiBiz Growth Report for June 21, 2020.
Perrigo sells generic drug biz to U.K. pharmaceutical company
Perrigo Co. plc has sold its generic prescription drug business to United Kingdom-based Rosemont Pharmaceuticals Ltd for $195 million in cash.
Perrigo makes $50M strategic investment in Colorado CBD producer
Perrigo Co. plc plans to enter the CBD market through a strategic investment and a long-term agreement with a Colorado supplier.
Perrigo sales up as consumers seek self-care products during pandemic
ALLEGAN — Higher consumer demand to treat symptoms of COVID-19 pushed Perrigo Co. plc to a 14-percent increase in sales growth for the first quarter.
Perrigo reports strong sales growth during COVID-19 pandemic
ALLEGAN — Perrigo Co. plc recorded strong double-digit sales growth for the first quarter, as demand spiked for over-the-counter medications in March in the COVID-19 pandemic.